生命科学资讯

Biotech venture firm Apple Tree goes bankrupt amid dispute with billionaire backer

Lilly’s three-pronged drug puts obesity field ‘on notice’

Crapo, Cassidy propose enhanced ACA subsidy alternative

Prolynx banks $70M for longer-lasting obesity drugs

FDA approves first drug in National Priority Voucher program

A former Roivant spinout bets on AI-designed drugs for immune conditions

Novartis notches another win for drug acquired in MorphoSys deal

Pfizer dips into China for another try at an obesity pill

FDA raises CAR-T approval standards; Novartis bets on an AI startup

J&J’s ‘remarkable’ Tecvayli data support earlier use in multiple myeloma

Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment

Mirum gains a hepatitis D drug in $620M buyout of startup Bluejay

Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar

How digital companion apps unlock value across the drug lifecycle

At ASH, Lilly makes case to widen Jaypirca use in leukemia, lymphoma

Vertex CRISPR therapy hits early goal in children with blood disorders

RFK Jr.’s hand-picked panel questions childhood vaccine schedule

Hemophilia gene therapies are struggling on the market, even as innovation soars

Praxis soars higher; Bristol Myers’ CAR-T therapy wins broader use

CDC panel again postpones vote on newborns’ hepatitis B shot